Effect of mebendazole on human cystic echinococcosis: the role of dosage and treatment duration

Citation
K. Vutova et al., Effect of mebendazole on human cystic echinococcosis: the role of dosage and treatment duration, ANN TROP M, 93(4), 1999, pp. 357-365
Citations number
24
Categorie Soggetti
Envirnomentale Medicine & Public Health","Medical Research General Topics
Journal title
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY
ISSN journal
00034983 → ACNP
Volume
93
Issue
4
Year of publication
1999
Pages
357 - 365
Database
ISI
SICI code
0003-4983(199906)93:4<357:EOMOHC>2.0.ZU;2-4
Abstract
Fifty-three patients with single, multiple and/or multi-organ hydatid cysts were treated with mebendazole, in varying dosages (30-70 mg/kg.day) and ov er varying periods (6-24 months). Treatment failure was recorded if the meb endazole had no apparent effect on cyst morphology (monitored by radiology, ultrasonography and computed tomography) or only a parasitostatic effect ( characterized by mixed and transitory, hypo- and hyper-echoic changes in th e lesions). Cure was indicated by a parasitocidal effect (characterized by a totally echogenic picture, increased density of the cyst contents, reduct ion in the size or complete disappearance of the cysts, complete detachment of the endocysts and/or calcification of the cyst wall). Treatment failure was seen in about 40% of the patients and cure in about 3 8%; the other 23% had an intermediate result considered as an improvement. Cure rates increased both with dosage and duration, daily dosages of 60-70, 50 and 30-40 mg/kg curing 48%, 33% and 25%, respectively. The pre-treatmen t condition of any cysts should be taken into consideration when determinin g dosage and treatment duration.